Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATDC_Nantes in Living-Donor Kidney Transplant Recipients
NCT02252055Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Mar 2015
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
A Phase 2 trial of ATDC_Nantes in end stage renal disease (ESRD), sponsored by CHU de Nantes. Started Mar 2015; status: completed.
02
Drugs
ATDC_Nantes
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02252055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252055.